AOD-9604 (5mg Vial)

01 · At a glance

Quickstart Highlights

AOD-9604 dosage protocol is designed to support targeted fat loss and metabolic improvements through daily subcutaneous injections. Typical starting dose between 300–400 mcg per day Once-daily injection schedule (can split doses in advanced protocol) Gradual dose titration to manage tolerance and optimize results Reconstitute with ~3 mL bacteriostatic water (≈1.67 mg/mL solution) Store lyophilized peptide frozen; refrigerate solution after mixing

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = 1.67 mg/mL)

Reference dose shown on this page: See guide.

Advanced / Aggressive Approach

Reconstitution Steps

1. Confirm the vial amount, unit, and diluent amount before entering values in the calculator.
2. Add diluent slowly down the inner wall of the vial when reconstitution is appropriate for the compound.
3. Swirl or roll gently until dissolved; avoid shaking unless the product instructions specifically say otherwise.
4. Label the vial with the date and concentration, then store according to the protocol and product instructions.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Protocol Overview

• Goal: Promote targeted fat loss and metabolic support
• Schedule: Daily subcutaneous injections for 8–12 weeks
• Dose Range: Start at ~300 mcg/day, titrate up to 500 mcg/day if needed
• Reconstitution: Use ~3 mL bacteriostatic water (≈1.67 mg/mL)
• Storage: Freeze vials (−20°C); refrigerate reconstituted solution (2–8°C):contentReference[oaicite:1]{index=1}

Dosing Protocol

• Suggested daily injection approach with gradual titration.
• Start Dose: 300 mcg once daily (fasted or pre-workout) Titration: Increase by 100 mcg every 2–4 weeks as tolerated
• Frequency: Once daily (advanced: consider twice daily split dosing)
• Cycle Length: 8–12 weeks (extend with breaks if needed) Maximum Dose: Up to 500 mcg daily (over 1 mg shows no added benefit)

Storage Instructions

• Review the source instructions and storage notes before handling any vial.
• Storage: Freeze vials (−20°C); refrigerate reconstituted solution (2–8°C):contentReference[oaicite:1]{index=1}
• Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

• Practical tips to enhance safety and efficacy.
• Always use new, sterile insulin syringes & rotate injection sites (abdomen, thigh, etc.).
• Maintain consistent dosing time each day for best results.
• Monitor for any adverse reactions; consult healthcare provider if needed.
• Track your progress and adjust dose cautiously under guidance.

05 · How it works

How This Works

AOD-9604 dosage protocol is designed to support targeted fat loss and metabolic improvements through daily subcutaneous injections.

Typical starting dose between 300–400 mcg per day Once-daily injection schedule (can split doses in advanced protocol) Gradual dose titration to manage tolerance and optimize results Reconstitute with ~3 mL bacteriostatic water (≈1.67 mg/mL solution) Store lyophilized peptide frozen; refrigerate solution after mixing

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

• Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
• Track body metrics only if they are relevant to the user's goal and approved data sources.
• Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

• AOD-9604 observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
• This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

09 · Evidence

References